Basic-Fit N.V. (AMS:BFIT)

Verve Therapeutics Balance Sheet

Financials in millions EUR. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	36.7	56.7	70.9	43.51	70.1	70.41
Trading Asset Securities	-	-	1.8	2.05	-	-
Cash & Short-Term Investments	36.7	56.7	72.7	45.56	70.1	70.41
Cash Growth	4.73%	-22.01%	59.59%	-35.02%	-0.43%	5.89%
Accounts Receivable	51.1	45.1	41.4	35.65	9.42	16.02
Other Receivables	41.6	38.9	34.3	36.05	53.31	25.17
Receivables	92.7	84	75.7	71.7	62.72	41.19
Inventory	27.4	29.2	23.8	20.89	31.71	8.15
Prepaid Expenses	-	13.7	4.7	5.24	9.54	2.72
Total Current Assets	156.8	183.6	176.9	143.38	174.08	122.46
Property, Plant & Equipment	3,022	2,994	2,716	2,372	2,043	1,851
Long-Term Investments	2.6	1.8	0.8	-	-	-
Goodwill	215.8	215.8	204.8	204.84	203.6	203.6
Other Intangible Assets	42.4	45.1	43.9	42.58	43.64	48.65
Long-Term Deferred Tax Assets	87.4	82.7	82	78.74	76.47	45.53
Other Long-Term Assets	17.5	17.1	10.1	8.91	6.74	5.81
Total Assets	3,544	3,540	3,235	2,850	2,548	2,278
Accounts Payable	210.9	123.1	120.5	149.17	121.43	70.1
Accrued Expenses	-	30	26.3	23.29	16.87	17.19
Current Portion of Long-Term Debt	307.5	1.6	18	13.33	101.54	64.41
Current Portion of Leases	282.4	272.2	254	216.45	196.14	174.17
Current Income Taxes Payable	4.8	3.4	0.5	1.86	0.02	0.01
Current Unearned Revenue	28	33.2	29.9	17.44	18.69	46.57
Other Current Liabilities	3.9	106.6	111.5	33.32	54.64	25.65
Total Current Liabilities	837.5	570.1	560.7	454.86	509.33	398.08
Long-Term Debt	757.9	998	863.5	723.78	518.08	548.37
Long-Term Leases	1,552	1,557	1,405	1,265	1,109	1,013
Long-Term Deferred Tax Liabilities	1.6	1	0.3	-	-	6.13
Other Long-Term Liabilities	2.7	2.6	0.8	1.29	0.85	0.82
Total Liabilities	3,152	3,129	2,831	2,445	2,137	1,967
Common Stock	4	4	4	3.96	3.96	3.6
Additional Paid-In Capital	690.5	690.5	690.5	690.53	690.53	490.03
Retained Earnings	-340.1	-333.2	-342	-338.69	-334.56	-184.51
Treasury Stock	-13.5	-2.7	-	-	-	-
Comprehensive Income & Other	51.1	52.9	51.5	49.6	50.66	1.59
Shareholders' Equity	392	411.5	404	405.4	410.58	310.7
Total Liabilities & Equity	3,544	3,540	3,235	2,850	2,548	2,278
Total Debt	2,900	2,829	2,541	2,219	1,925	1,800
Net Cash (Debt)	-2,863	-2,772	-2,468	-2,173	-1,855	-1,730
Net Cash Per Share	-43.53	-38.54	-34.28	-32.93	-28.94	-30.03
Filing Date Shares Outstanding	65.38	65.88	66	66	66	60
Total Common Shares Outstanding	65.38	65.88	66	66	66	60
Working Capital	-680.7	-386.5	-383.8	-311.48	-335.24	-275.62
Book Value Per Share	6.00	6.25	6.12	6.14	6.22	5.18
Tangible Book Value	133.8	150.6	155.3	157.98	163.34	58.45
Tangible Book Value Per Share	2.05	2.29	2.35	2.39	2.47	0.97
Land	-	-	-	2	2	2
Buildings	1,643	1,573	1,310	1,040	855.36	735.11

Updated Mar 12, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.